PH27400A - New therapeutically active compound and method of use thereof - Google Patents
New therapeutically active compound and method of use thereofInfo
- Publication number
- PH27400A PH27400A PH39732A PH39732A PH27400A PH 27400 A PH27400 A PH 27400A PH 39732 A PH39732 A PH 39732A PH 39732 A PH39732 A PH 39732A PH 27400 A PH27400 A PH 27400A
- Authority
- PH
- Philippines
- Prior art keywords
- active compound
- therapeutically active
- new therapeutically
- new
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19888804629A SE8804629D0 (sv) | 1988-12-22 | 1988-12-22 | New therapeutically active compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PH27400A true PH27400A (en) | 1993-06-21 |
Family
ID=20374310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH39732A PH27400A (en) | 1988-12-22 | 1989-12-19 | New therapeutically active compound and method of use thereof |
Country Status (32)
Country | Link |
---|---|
US (2) | US5008278A (fr) |
EP (1) | EP0449940B1 (fr) |
JP (1) | JP2793906B2 (fr) |
KR (1) | KR910700249A (fr) |
CN (1) | CN1028231C (fr) |
AR (1) | AR248136A1 (fr) |
AT (1) | ATE127799T1 (fr) |
AU (1) | AU634741B2 (fr) |
BG (1) | BG60102B2 (fr) |
CA (1) | CA2005986C (fr) |
DD (2) | DD296078A5 (fr) |
DE (1) | DE68924273T2 (fr) |
DK (1) | DK170800B1 (fr) |
EG (1) | EG19303A (fr) |
FI (2) | FI913035A0 (fr) |
GR (1) | GR1002252B (fr) |
HR (1) | HRP920831A2 (fr) |
HU (2) | HU205927B (fr) |
IE (1) | IE894048L (fr) |
IL (1) | IL92798A0 (fr) |
LT (2) | LT3980B (fr) |
LV (1) | LV10187B (fr) |
NZ (1) | NZ231872A (fr) |
PH (1) | PH27400A (fr) |
PL (1) | PL161150B1 (fr) |
PT (1) | PT92648B (fr) |
RO (1) | RO110494B1 (fr) |
RU (2) | RU2073676C1 (fr) |
SE (1) | SE8804629D0 (fr) |
WO (1) | WO1990006925A1 (fr) |
YU (1) | YU46806B (fr) |
ZA (2) | ZA899794B (fr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ244301A (en) * | 1991-09-20 | 1994-08-26 | Merck & Co Inc | Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds |
TNSN95063A1 (fr) * | 1994-05-27 | 1996-02-06 | Astra Ab | Nouveaux benzimidazoles substitues |
EP0723436B1 (fr) * | 1994-07-08 | 2001-09-26 | AstraZeneca AB | Forme posologique sous forme de comprime composite (i) |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
DE19758573C2 (de) * | 1997-11-26 | 2001-03-01 | Implex Hear Tech Ag | Fixationselement für ein implantierbares Mikrofon |
WO1999053918A1 (fr) * | 1998-04-20 | 1999-10-28 | Eisai Co., Ltd. | Compositions stabilisees contenant des composes du type benzimidazole |
TWI243672B (en) | 1999-06-01 | 2005-11-21 | Astrazeneca Ab | New use of compounds as antibacterial agents |
WO2001028559A1 (fr) | 1999-10-20 | 2001-04-26 | Eisai Co., Ltd. | Procede de stabilisation de composes benzimidazoles |
SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
MXPA04007169A (es) * | 2002-01-25 | 2004-10-29 | Santarus Inc | Suministro transmucosal de inhibidores de bomba de protones. |
US20050234103A1 (en) * | 2002-03-26 | 2005-10-20 | Reddy Manne S | Crystalline forms of rabeprazole sodium |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
CA2517005A1 (fr) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | Liberation immediate d'un complexe antacide d'omeprazole presentant une nouvelle formulation pour une elimination rapide et prolongee d'acide gastrique |
US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
WO2005007115A2 (fr) * | 2003-07-18 | 2005-01-27 | Santarus, Inc. | Formulations pharmaceutiques utilisees pour inhiber une secretion acide et procede de fabrication associe |
AR045061A1 (es) * | 2003-07-18 | 2005-10-12 | Santarus Inc | Formulacion farmaceutica y metodo para tratar trastornos gastrointestinales causados por acido |
ATE544447T1 (de) | 2003-09-26 | 2012-02-15 | Alza Corp | Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
RU2467747C2 (ru) | 2006-07-25 | 2012-11-27 | Векта Лтд. | Композиции и способы для ингибирования секреции желудочной кислоты с использованием производных малых дикарбоновых кислот в сочетании с ppi |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
CA2736547C (fr) | 2008-09-09 | 2016-11-01 | Pozen Inc. | Procede d'administration d'une composition pharmaceutique a un patient en ayant besoin |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
WO2011080501A2 (fr) | 2009-12-29 | 2011-07-07 | Orexo Ab | Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique |
WO2011080500A2 (fr) | 2009-12-29 | 2011-07-07 | Orexo Ab | Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique |
WO2011080502A2 (fr) | 2009-12-29 | 2011-07-07 | Orexo Ab | Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique |
EP2601947A1 (fr) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Combinaison à dose fixe pour le traitement de maladies associées à Hélicobacter pylori |
MX2014007935A (es) | 2011-12-28 | 2014-11-14 | Pozen Inc | Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico. |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US428098A (en) | 1890-05-20 | Electric railway | ||
US727150A (en) | 1902-06-18 | 1903-05-05 | Peter Paul Keller | Adjustable hanger for incandescent lamps. |
SE418966B (sv) * | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
IN148930B (fr) * | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
DE3215503A1 (de) | 1982-04-26 | 1983-11-03 | Zängl GmbH, 8000 München | Elektrisch beheiztes schneidgeraet |
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
IL71664A (en) * | 1983-05-03 | 1987-11-30 | Byk Gulden Lomberg Chem Fab | Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
JPS6150979A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
AU568441B2 (en) * | 1984-09-24 | 1987-12-24 | Upjohn Company, The | 2-(pyridylalkenesulfinyl) benzimidazole derivatives |
US4738975A (en) * | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
JPS6261978A (ja) * | 1985-09-12 | 1987-03-18 | Otsuka Pharmaceut Co Ltd | 5−フルオロ−1h−ベンズイミダゾ−ル誘導体 |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
JPS62201884A (ja) * | 1986-02-28 | 1987-09-05 | Tokyo Tanabe Co Ltd | ベンズイミダゾール誘導体及びその製造法 |
FI90544C (fi) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
NZ234564A (en) * | 1986-11-21 | 1991-04-26 | Haessle Ab | 1-substituted benzimidazoles and pharmaceutical compositions |
FI96860C (fi) * | 1987-06-17 | 1996-09-10 | Eisai Co Ltd | Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi |
DE3722810A1 (de) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung |
DK171989B1 (da) * | 1987-08-04 | 1997-09-08 | Takeda Chemical Industries Ltd | Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler |
JPH0676323B2 (ja) * | 1987-08-28 | 1994-09-28 | 東京田辺製薬株式会社 | 抗潰瘍剤 |
-
1988
- 1988-12-22 SE SE19888804629A patent/SE8804629D0/xx unknown
-
1989
- 1989-12-18 AR AR89315705A patent/AR248136A1/es active
- 1989-12-18 IE IE894048A patent/IE894048L/xx unknown
- 1989-12-18 EG EG62189A patent/EG19303A/xx active
- 1989-12-19 IL IL92798A patent/IL92798A0/xx not_active IP Right Cessation
- 1989-12-19 CA CA002005986A patent/CA2005986C/fr not_active Expired - Lifetime
- 1989-12-19 NZ NZ231872A patent/NZ231872A/en unknown
- 1989-12-19 GR GR890100838A patent/GR1002252B/el unknown
- 1989-12-19 PH PH39732A patent/PH27400A/en unknown
- 1989-12-20 DD DD89335980A patent/DD296078A5/de not_active IP Right Cessation
- 1989-12-20 EP EP90901079A patent/EP0449940B1/fr not_active Expired - Lifetime
- 1989-12-20 ZA ZA899794A patent/ZA899794B/xx unknown
- 1989-12-20 HU HU901095A patent/HU205927B/hu not_active IP Right Cessation
- 1989-12-20 WO PCT/SE1989/000740 patent/WO1990006925A1/fr active Application Filing
- 1989-12-20 HU HU901084A patent/HU205926B/hu not_active IP Right Cessation
- 1989-12-20 ZA ZA899795A patent/ZA899795B/xx unknown
- 1989-12-20 DE DE68924273T patent/DE68924273T2/de not_active Expired - Fee Related
- 1989-12-20 DD DD89335981A patent/DD296079A5/de not_active IP Right Cessation
- 1989-12-20 RU SU894895789A patent/RU2073676C1/ru active
- 1989-12-20 AT AT90901079T patent/ATE127799T1/de not_active IP Right Cessation
- 1989-12-20 AU AU48175/90A patent/AU634741B2/en not_active Ceased
- 1989-12-20 JP JP2501537A patent/JP2793906B2/ja not_active Expired - Fee Related
- 1989-12-20 US US07/454,047 patent/US5008278A/en not_active Expired - Lifetime
- 1989-12-20 RO RO147866A patent/RO110494B1/ro unknown
- 1989-12-21 YU YU242689A patent/YU46806B/sh unknown
- 1989-12-21 PT PT92648A patent/PT92648B/pt not_active IP Right Cessation
- 1989-12-21 CN CN89109587A patent/CN1028231C/zh not_active Expired - Fee Related
- 1989-12-22 PL PL1989282923A patent/PL161150B1/pl unknown
-
1990
- 1990-08-21 KR KR1019900701828A patent/KR910700249A/ko not_active Application Discontinuation
- 1990-12-20 US US07/633,007 patent/US5039808A/en not_active Expired - Lifetime
-
1991
- 1991-06-19 BG BG094659A patent/BG60102B2/bg unknown
- 1991-06-20 FI FI913035A patent/FI913035A0/fi not_active Application Discontinuation
- 1991-06-21 DK DK122291A patent/DK170800B1/da not_active IP Right Cessation
- 1991-06-21 RU SU914895805A patent/RU2042673C1/ru active
-
1992
- 1992-10-02 HR HR920831A patent/HRP920831A2/hr not_active Application Discontinuation
-
1993
- 1993-06-30 LV LVP-93-860A patent/LV10187B/en unknown
- 1993-12-30 LT LTIP1721A patent/LT3980B/lt not_active IP Right Cessation
- 1993-12-30 LT LTIP1726A patent/LT3914B/lt not_active IP Right Cessation
-
1995
- 1995-10-06 FI FI954768A patent/FI954768A0/fi not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH27400A (en) | New therapeutically active compound and method of use thereof | |
AU584469B2 (en) | Lightweight nonwoven tissue and method of manufacture | |
EP0203768A3 (en) | A therapeutic effervescent composition and a method of preparing the same | |
AU5947886A (en) | Tablet package and method of use | |
GB2215267B (en) | Disposable faceshield and method of manufacture thereof | |
PH23495A (en) | Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof | |
IL98618A0 (en) | Improved ointment base and method of use | |
PH21588A (en) | Pleuromutilin derivatives and method of use thereof | |
AU587182B2 (en) | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters | |
HU893412D0 (en) | Inhibitors of interleucin-1 | |
AU590640B2 (en) | Dementia-improving and therapeutic agents | |
ZA899778B (en) | Reduction of piperidine-dion-derivatives and intermediates | |
ZA897446B (en) | Antimicrobial composition and method of use | |
AU576717B2 (en) | N6 - bicycloadenosines and methods of use | |
ZA876845B (en) | Pharmacologically active compounds and use | |
JPS6450846A (en) | Arylbisperfluoroalkylcarbinol and manufacture of same | |
GB2220652B (en) | Treatment of pastures | |
ZA874979B (en) | Pharmacologically active compounds and use | |
PH22427A (en) | Eburnamenine derivatives and method of use thereof | |
ZA846720B (en) | Process for the preparation of a therapeutically active compound and a new therapeutical use of the same | |
AU4219789A (en) | Treatment of superconducting materials | |
PL271176A1 (en) | Method of obtaining active aluminium oxide | |
PL271175A1 (en) | Method of obtaining active aluminium oxide | |
YU62088A (en) | Rolling of roll-cotton | |
ZA852625B (en) | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters |